Microbes Fight Chronic Infection

Gut microbiome analysis reveals protective bacteria that enhance resistance to persistent Clostridium difficile infections.

Written byChris Palmer
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share


Clostridium difficile sporesWIKIMEDIA, CJC2ND
Patients who’d rather not ingest another’s fecal matter to fight tenacious cases of Clostridium difficile infections (CDI) may soon have a less stomach-turning, and perhaps safer, alternative. According to a genetic sequencing analysis of intestinal microbes, a small handful of bacterial species may be all that are needed to restore health. The study, published today (October 23) in Nature, suggests that the bacteria protect against infection by altering the composition of bile acids in the gut.

While antibiotics work wonders fighting myriad infections, they can also wipe out the large contingent of beneficial bacteria that populate the human gut. Such widespread, indiscriminate destruction paves the way for infectious pathogens, including C. difficile—which can cause extreme diarrhea, abdominal pain, and if left untreated, even death. In the past decade, CDI has grown to epidemic proportions in hospitals around the country with nearly a quarter of a million Americans affected every year. Vanquishing C. difficile is especially challenging because, while a standard regimen of antibiotics can eliminate the majority of infections, residual amounts of the bacterium’s spores can survive the acidity of the stomach, allowing the bacteria to resurface weeks or months later.

A recent medical trend has seen patients with recurring CDI ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform